Home
About Us
Product Pipeline
Investors & Media
Careers
Subscribe

Our Company
Our Values
Our Strategy
Meet the Management Team
Our Board Members

Product Pipeline

Selective GPR84 Antagonist
Selective OXER1 Antagonist

Investors & Media

Investor Resources
Press Releases
Financial Reports
Webcasts
SEC Filings
SEDAR® Filings
Stock Information
Corporate Governance
Investor Briefcase
Frequently Asked Questions

Career Opportunities
Resume Submission

Contact Us

Home
About Us
Product Pipeline
- Selective GPR84 Antagonist
- Selective OXER1 Antagonist

Investors & Media
Careers
Subscribe

Investors Home
News & Events
- Press Releases
- Events
Financial Reports
- SEC Filings
- SEDAR® Filings
Stock Information
- Interactive Chart
Corporate Governance
Shareholder Information
Resources

Investor Resources

Corporate Governance

Category Keywords

Human Resources & Corporate Governance Committee Charter
Audit, Risk and Finance Committee Charter
Certificate of Amendment – January 25, 2023.
Code of Ethics and Business Conduct
Majority Voting Policy
Board of Directors Charter
Board Committees: Chair Mandate
CEO Position Description
Mandate of the Chair of the Board of Directors
Position Description for the Lead Independent Director of the Board of Directors
By-Law No.3
By-Law No.2
Amendment to By-Law No.1 - June 8, 2020
Amendment to By-Law No.1 - May 3, 2006
By-Law No.1
Articles of Amendment - June 16, 2020
Certificate of Amendment - February 16, 2000
Certificate of Amendment - October 3, 2019
Certificate of Amendment - June 28, 2019
Certificate of Amendment - November 13, 2018
Certificate of Amendment - June 1, 2017
Certificate of Amendment - January 25, 2013
Certificate of Amendment - May 15, 2008
Restated Articles of Incorporation - May 19, 1998

Show 5 10 25 50 100 per page

© 2023 Liminal BioSciences Inc. All Rights Reserved. | Legal Disclaimer | Privacy Policy | Cookie Policy | Social Media Guidelines